Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Results vary for each individual
Feb 2019;42(1):46-52
Exenatide-treated patients had a mean 2.7 point improvement on the MDS-UPDRS, compared to a mean decline of 2.2 points in controls
These medications have been shown to reduce body weight anywhere from 10-20%, depending on which GLP-1 agonist is used
Choosing between them, or using them in tandem, depends on whether your primary goal is cost-effective glucose management or more aggressive metabolic and cardiovascular intervention.
US$ 21.98
US$ 24.64
US$ 29.69
US$ 29.08
US$ 26.32
US$ 29.12
US$ 22.22
US$ 21.76
US$ 29.75
US$ 29.76
